Cargando…
The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
Surgical treatment is the only possible cure for cholangiocarcinoma (CCA) at present. However, the high recurrence rate of postoperative CCA leads to a very poor prognosis for patients, effective postoperative chemotherapy is hence the key to preventing the recurrence of CCA. The sensitivity of CCA...
Autores principales: | Wu, Jun, Sheng, Jiyao, Qin, Hanjiao, Cui, Mengying, Yang, Yongsheng, Zhang, Xuewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339899/ https://www.ncbi.nlm.nih.gov/pubmed/34367944 http://dx.doi.org/10.3389/fonc.2021.628636 |
Ejemplares similares
-
Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
por: Gao, Yang, et al.
Publicado: (2021) -
Drug-Resistant Epilepsy and Surgery
por: Sheng, Jiyao, et al.
Publicado: (2018) -
Advances in Renal Cell Carcinoma Drug Resistance Models
por: Xiang, Yien, et al.
Publicado: (2022) -
Mitochondrial Quality Control in Hepatocellular Carcinoma
por: Bian, Jinda, et al.
Publicado: (2021) -
Precision diagnosis of hepatocellular carcinoma
por: Wang, Zhenxiao, et al.
Publicado: (2023)